Marshall Wace’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Marshall Wace's PCRX Position: Q3 2026 in Review
Marshall Wace increased its Pacira BioSciences (PCRX) stake by 85% in Q3 2026, buying an estimated $2.8M and bringing the position to 239,881 shares worth $6.01M. The position accounts for 0.01% of the portfolio, ranked #1242.
Marshall Wace first reported a position in PCRX in Q3 2015 and has held it in 21 quarters since. The position peaked at $27.8M in Q2 2024. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Marshall Wace held 239,881 shares of Pacira BioSciences worth $6.01M as of Q3 2026.
- Marshall Wace bought 110,533 Pacira BioSciences shares in Q3 2026, an estimated $2.8M.
- Pacira BioSciences made up 0.01% of Marshall Wace's portfolio in Q3 2026, its #1242 holding.
- Marshall Wace first reported a position in Pacira BioSciences in Q3 2015 and has held it in 21 quarters since.
- Marshall Wace's Pacira BioSciences position peaked at $27.8M in Q2 2024.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.